Date
2020/4/7
2020/4/14
2020/4/21
2020/4/28

2020/5/12
2020/5/19

2020/5/26

2020/6/2
2020/6/9
2020/6/16

2020/6/23

2020/6/30

Presenter Title
Venetoclax Plus LDAC for Patients With Untreated AML Ineligible for Intensive Chemotherapy:
山田
Phase 3 Randomized Placebo-Controlled Trial
Mutational Spectrum and Dynamics of Clonal Hematopoiesis in Anemia of Older Individuals
宮﨑A Multicenter Retrospective Study of 223 Patients With t(14;16) in Multiple Myeloma.
児嶋Clonal Hematopoiesis in Elderly Twins: Concordance, Discordance, and Mortality.
佐藤
Clinical Impact of Clonal Hematopoiesis in Patients With Lymphoma Undergoing ASCT:新山
A National Population-Based Cohort StudyJALSGで実施中の臨床試験について波多
Clinical and Functional Significance of Circular RNAs in Cytogenetically Normal AML
藤岡Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia:
波多
A Report From the Children's Oncology Group
Eltrombopag for Patients With Moderate Aplastic Anemia or Uni-Lineage Cytopenias
千綿A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease
長井A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with桐野
high-risk APL (SWOG 0535).
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with
加藤
Therapeutic Implications.
Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia
坂本
Oral Brincidofovir Decreases the Incidence of HHV-6B Viremia After Allogeneic HCT
澤山
を中心としたbrincidofovirのreview
Reduced-intensity Haploidentical Peripheral Blood Stem Cell Transplantation Using Low-Dose渡辺
Thymoglobulin for Aggressive Adult T Cell leukemia/lymphoma Patients in Non-Complete Remission
Genomic Landscape of Young ATLL Patients Identifies Frequent Targetable CD28 Fusions
今泉
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
山田
Extensive Remodeling of the Immune Microenvironment in B Cell Acute Lymphoblastic Leukemia
安東Characteristics and Outcomes of Patients With Therapy-Related Acute Myeloid Leukemia With児嶋
Normal Karyotype
FLT3 Inhibition Upregulates HDAC8 via FOXO to Inactivate p53 and Promote Maintenance of佐藤FLT3-ITD+ Acute Myeloid Leukemia
Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With
クリクラ
Untreated Burkitt Lymphoma
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
新山
Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem藤岡
cell transplantation
Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia
宮崎Journal

Year

Vol

Page

Blood

2020

27-MarOnline ahead of print.

Blood
Am J Hematol.
Blood

2020
2020
2020

135 (14)95(5)135(4)

1161-1170
503-509261-268.

Leukemia

2020

20-MarOnline ahead of print.

Blood Adv

2020

4(2)

239-251

J Clin Oncol

2020

10-AprOnline ahead of print.

Blood Adv
Blood Adv2020
2020

4(8)
4(8)

1700-1710
1656-1669

Blood Adv

2020

4(8)

1683-1689

Cancer Cell

2020

37(4)

551-568

Nat commun

2019

10(1)

4869

Blood2020

135(17)1447-1451

Ann Hematol

2020

99(3)

599-607

Blood
N Eng J Med
Cancer Cell

2019
2020
2020

135(17)382(6)
37(6)1467-1471
545-553867-882

Blood Cancer J 2020

10(5)Blood2020

135(17)1472-1483

J Clin Oncol

2020

26-MayOnline ahead of print.

N Eng J Med

2020

382(14)1331-1342

Blood2020

135(18)1548-1559

J Clin Invest

2020

130(2)

981-997